Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults

The pooled incidences of treatment-emergent adverse events (TEAEs) were examined by indication using the integrated clinical database of Merz-sponsored, placebo-controlled, or repeat-dose studies of incobotulinumtoxinA in adults with cervical dystonia, blepharospasm, limb spasticity, sialorrhea, or...

Full description

Bibliographic Details
Main Authors:	Wolfgang H. Jost, Petr Kaňovský, Michael A. Hast, Angelika Hanschmann, Michael Althaus, Atul T. Patel
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Toxins
Subjects:	incobotulinumtoxinA cervical dystonia blepharospasm spasticity sialorrhea essential tremor
Online Access:	https://www.mdpi.com/2072-6651/15/6/353

Similar Items

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
by: Steffen Berweck, et al.
Published: (2022-08-01)

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
by: Koji Makino, et al.
Published: (2020-03-01)

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Alberto Albanese, et al.
Published: (2023-05-01)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Jörg Wissel, et al.
Published: (2021-12-01)

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
by: Yoshihisa Masakado, et al.
Published: (2022-03-01)

Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01)

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
by: Franco Molteni, et al.
Published: (2023-12-01)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
by: Klemens Fheodoroff, et al.
Published: (2020-03-01)

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study
by: Cynthia Comella, et al.
Published: (2022-01-01)

Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea
by: A. L. Kurenkov, et al.
Published: (2022-04-01)

Botulinum toxin A (IncobotulinumtoxinA) and pneumoperitoneum image-guided for hernia repair with loss of dominance
by: Sergio E. López-Juárez, et al.
Published: (2023-01-01)

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
by: Harald Hefter, et al.
Published: (2021-02-01)

Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial
by: David Faustino Ângelo, et al.
Published: (2023-06-01)

Effects of Ultrasound-Guided Administration of Botulinum Toxin (IncobotulinumtoxinA) in Patients with Lateral Epicondylitis
by: Antonio Galván Ruiz, et al.
Published: (2019-01-01)

IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2021-08-01)

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
by: Wolfgang H. Jost
Published: (2021-01-01)

Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA
by: Jörg Wissel, et al.

Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience
by: Javier Martínez-Poles, et al.
Published: (2018-05-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
by: Ruth Kent, et al.
Published: (2021-07-01)

Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
by: Carolina Gorodetsky, et al.
Published: (2021-07-01)

Can Incobotulinumtoxin-A Treatment Improve Quality of Life Better Than Conventional Therapy in Spastic Muscle Post-Stroke Patients? Results from a Pilot Study from a Single Center
by: Adina Turcu-Stiolica, et al.
Published: (2021-07-01)

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA
by: de Sanctis Pecora C
Published: (2020-02-01)

Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone
by: Anido J, et al.
Published: (2017-10-01)

Botulinum toxin therapy (Incobotulinumtoxin А) in the complex rehabilitation of adolescents with cerebral palsy (clinical case)
by: E. V. Kostenko, et al.
Published: (2018-05-01)

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
by: Kaku M, et al.
Published: (2016-03-01)

Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic
by: Ganesh Bavikatte, et al.
Published: (2021-08-01)

Historical aspects of studying craniocervical dystonia
by: Zifa G. Khayatova, et al.
Published: (2019-12-01)

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
by: Joseph Jankovic, et al.
Published: (2023-05-01)

IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series
by: da Cunha ALG, et al.
Published: (2023-03-01)

Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania
by: Adina Turcu-Stiolica, et al.
Published: (2020-01-01)

A Case with Improvement of Blepharospasm by Zolpidem
by: Munkyung Sunwoo, et al.
Published: (2011-05-01)

Sialorrhea in Parkinson’s Disease
by: Jonathan Isaacson, et al.
Published: (2020-10-01)

Genetic Screening of a Hungarian Cohort with Focal Dystonia Identified Several Novel Putative Pathogenic Gene Variants
by: András Salamon, et al.
Published: (2023-06-01)

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
by: Fraint A, et al.
Published: (2016-02-01)

FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)

Sexual dysfunction in cervical dystonia and blepharospasm
by: Marek M, et al.
Published: (2018-10-01)

Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data
by: François Giuliano, et al.
Published: (2023-06-01)

Genetic Update and Treatment for Dystonia
by: Jan Koptielow, et al.
Published: (2024-03-01)

Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm
by: Hannah Mary Timlin, et al.
Published: (2021-01-01)